Ardeypharm GmbH   Report issue

For profit Phase 3
Founded: Herdecke Germany (1953)
Status: No NME R&D (1953)

Organization Overview

First Clinical Trial
2014
NCT02144948
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

escherichia coli nissle 1917 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Infections (Phase 3)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1